A. Mone

发表

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

J. Byrd, T. Lin, D. Young, 2006, Leukemia.

pathway in human chronic lymphocytic leukemia cells Hu1D10 induces apoptosis concurrent with activation of the AKT survival

J. Byrd, H. Pelicano, Peng Huang, 2011 .

Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.

J. Byrd, A. Johnson, H. Pelicano, 2004, Blood.

Hu 1 D 10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells

J. Byrd, A. Johnson, H. Pelicano, 2004 .

Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.

J. Byrd, D. Jarjoura, X. Mo, 2010, Leukemia research.

Alemtuzumab Induces Cell Death in Human Chronic Lymphocytic Leukemia Cells through a Lipid Raft-Dependent Mechanism.

J. Byrd, C. Cheney, C. F. Eisenbeis, 2004 .

-refractory adult T-cell leukemia α load following alemtuzumab in AZT/IFN Durable hematological complete response and suppression of HTLV-1 viral

M. Caligiuri, J. Byrd, R. Baiocchi, 2013 .

Mitochondria control of cell death induced by anti-HLA-DR antibodies

J. Byrd, D. Lucas, J. Tso, 2003, Leukemia.

KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis.

M. Grever, J. Byrd, D. Lucas, 2003, Blood.

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.

M. Grever, J. Byrd, John Calvin Reed, 2003, Blood.

independent mechanism - Bcl-2 CLL cells and transformed B-cell lymphoma cell line via a caspase- and A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary

Lisa L. Smith, M. Grever, J. Byrd, 2013 .

A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism.

Lisa L. Smith, M. Grever, J. Byrd, 2004, Blood.

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells

M. Grever, J. Byrd, John Calvin Reed, 2004, Leukemia.

Central Pontine Myelinolysis: Delayed Changes on Neuroimaging

B. Troost, A. Mone, L. C. Gray, 2000, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Advances in the therapy of chronic lymphocytic leukemia.

J. Byrd, A. Johnson, A. Mone, 2003, Current opinion in hematology.

International Standardized Approach to Molecular and Flow Cytometric Residual Disease Monitoring in CLL.

J. Byrd, Y. Natkunam, E. Montserrat, 2004 .

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.

M. Caligiuri, J. Byrd, R. Baiocchi, 2005, Blood.

Arsenic Trioxide and Ascorbic Acid Enhances the Cytotoxicity of Hu1D10 towards CLL Cells.

J. Byrd, C. Sen, N. Muthusamy, 2004 .